<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36726984</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Exploring the causality and pathogenesis of systemic lupus erythematosus in breast cancer based on Mendelian randomization and transcriptome data analyses.</ArticleTitle><Pagination><StartPage>1029884</StartPage><MedlinePgn>1029884</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1029884</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.1029884</ELocationID><Abstract><AbstractText Label="INTRODUCTION">There has been a cumulative interest in relationships between systemic lupus erythematosus (SLE) and cancer risk. Breast cancer is the most common cancer among women worldwide. However, the casual association and pathogenesis between SLE and breast cancer remains incompletely unknown.</AbstractText><AbstractText Label="METHODS">Mendelian randomization (MR) analysis was first conducted to investigate the potential causality between SLE and breast cancer. Sensitivity analyses were applied to validate the reliability of MR results. Transcriptomic data analyses based on the Cancer Genome Atlas and Gene Expression Omnibus databases were then performed to identify and construct a SLE-related gene signature (SLEscore).</AbstractText><AbstractText Label="RESULTS">The MR analysis demonstrated that genetic predisposition to SLE was casually associated with the decreased risk of breast cancer in the East Asian cohort (odds ratios: 0.95, 95% confidence interval: 0.92-0.98, <i>p</i>=0.006). However, no casual associations were observed in the European population. Furthermore, sensitivity analyses proved the robustness of the present MR results. A prognostic SLEscore consisting of five SLE-related genes (<i>RACGAP1, HMMR, TTK, TOP2A</i>, and <i>KIF15</i>) could distribute patients with breast cancer into the high- and low-risk groups according to survival rates with good predictive ability (<i>p</i> &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION">Our MR study provided evidence that genetic changes in SLE were significantly associated with the decreased risk of breast cancer in the East Asian population, while no causality was found in the European cohorts. Transcriptome data analyses indicated that the SLEscore could serve as a novel biomarker for predicting prognosis when breast cancer and SLE coexisted in patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Li, Wang and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenjie</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486567">KIF15 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.4</RegistryNumber><NameOfSubstance UI="D016547">Kinesins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057182" MajorTopicYN="N">Mendelian Randomization Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016547" MajorTopicYN="N">Kinesins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mendelian randomization</Keyword><Keyword MajorTopicYN="N">breast cancer</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">transcriptomic data</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>2</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36726984</ArticleId><ArticleId IdType="pmc">PMC9885086</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1029884</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bakshi J, Segura B, Wincup C, Rahman A. Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus. Clin Rev Allergy Immunol (2018) 55(3):352&#x2013;67. doi:&#xa0;10.1007/s12016-017-8640-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-017-8640-5</ArticleId><ArticleId IdType="pmc">PMC6244922</ArticleId><ArticleId IdType="pubmed">28853005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L, Tong H, Xu G, Liu P, Meng H, Wang J, et al. . Systemic lupus erythematous and malignancy risk: A meta-analysis. PloS One (2015) 10(4):e0122964. doi:&#xa0;10.1371/journal.pone.0122964</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122964</ArticleId><ArticleId IdType="pmc">PMC4401738</ArticleId><ArticleId IdType="pubmed">25885411</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermann R, Zobbe K, Cordtz R, Haugaard J, Dreyer L. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study. Lupus (2021) 30(5):752&#x2013;61. doi:&#xa0;10.1177/0961203321990106</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203321990106</ArticleId><ArticleId IdType="pubmed">33497306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae E, Lim S, Han K, Jung J, Choi H, Kim C, et al. . Systemic lupus erythematosus is a risk factor for cancer: A nationwide population-based study in Korea. Lupus (2019) 28(3):317&#x2013;23. doi:&#xa0;10.1177/0961203319826672</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319826672</ArticleId><ArticleId IdType="pubmed">30712493</ArticleId></ArticleIdList></Reference><Reference><Citation>Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet (2021) 397(10286):1750&#x2013;69. doi:&#xa0;10.1016/s0140-6736(20)32381-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)32381-3</ArticleId><ArticleId IdType="pubmed">33812473</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahiraee A, Ebrahimi R, Halabian R, Aghabozorgi A, Amani J. The role of inflammation and its related micrornas in breast cancer: A narrative review. J Cell Physiol (2019) 234(11):19480&#x2013;93. doi:&#xa0;10.1002/jcp.28742</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.28742</ArticleId><ArticleId IdType="pubmed">31025369</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaieyazdi Z, Tabaei S, Ravanshad Y, Akhtari J, Mehrad-Majd H. No association between the risk of breast cancer and systemic lupus erythematosus: Evidence from a meta-analysis. Clin Rheumatol (2018) 37(6):1511&#x2013;9. doi:&#xa0;10.1007/s10067-017-3950-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-017-3950-9</ArticleId><ArticleId IdType="pubmed">29294194</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaliq W, Qayyum R, Clough J, Vaidya D, Wolff A, Becker D. Comparison of breast cancer risk in women with and without systemic lupus erythematosus in a Medicare population. Breast Cancer Res Treat (2015) 151(2):465&#x2013;74. doi:&#xa0;10.1007/s10549-015-3412-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10549-015-3412-5</ArticleId><ArticleId IdType="pmc">PMC4695988</ArticleId><ArticleId IdType="pubmed">25957594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu K, Kuo C, Huang L, Huang W, See L. Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: A nationwide population-based dynamic cohort study in Taiwan. Medicine (2016) 95(18):e3540. doi:&#xa0;10.1097/md.0000000000003540</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000003540</ArticleId><ArticleId IdType="pmc">PMC4863778</ArticleId><ArticleId IdType="pubmed">27149461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontos M, Fentiman I. Systemic lupus erythematosus and breast cancer. Breast J (2008) 14(1):81&#x2013;6. doi:&#xa0;10.1111/j.1524-4741.2007.00520.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4741.2007.00520.x</ArticleId><ArticleId IdType="pubmed">18186868</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruera S, Lei X, Pundole X, Zhao H, Giordano S, Vinod S, et al. . Systemic lupus erythematosus is a risk factor for mortality in elderly patients with early breast cancer. Arthritis Care Res (2021). doi:&#xa0;10.1002/acr.24793</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24793</ArticleId><ArticleId IdType="pubmed">34558796</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey Smith G, Ebrahim S. What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ (2005) 330(7499):1076&#x2013;9. doi:&#xa0;10.1136/bmj.330.7499.1076</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.330.7499.1076</ArticleId><ArticleId IdType="pmc">PMC557238</ArticleId><ArticleId IdType="pubmed">15879400</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentham J, Morris D, Graham D, Pinder C, Tombleson P, Behrens T, et al. . Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet (2015) 47(12):1457&#x2013;64. doi:&#xa0;10.1038/ng.3434</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3434</ArticleId><ArticleId IdType="pmc">PMC4668589</ArticleId><ArticleId IdType="pubmed">26502338</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang Y, Lin Z, Zhang H, Wang T, Cao Y, et al. . Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nat Commun (2021) 12(1):772. doi:&#xa0;10.1038/s41467-021-21049-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21049-y</ArticleId><ArticleId IdType="pmc">PMC7858632</ArticleId><ArticleId IdType="pubmed">33536424</ArticleId></ArticleIdList></Reference><Reference><Citation>Michailidou K, Lindstr&#xf6;m S, Dennis J, Beesley J, Hui S, Kar S, et al. . Association analysis identifies 65 new breast cancer risk loci. Nature (2017) 551(7678):92&#x2013;4. doi:&#xa0;10.1038/nature24284</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature24284</ArticleId><ArticleId IdType="pmc">PMC5798588</ArticleId><ArticleId IdType="pubmed">29059683</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele T, Tchetgen Tchetgen E, Cornelis M, Kraft P. Methodological challenges in mendelian randomization. Epidemiology (2014) 25(3):427&#x2013;35. doi:&#xa0;10.1097/ede.0000000000000081</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ede.0000000000000081</ArticleId><ArticleId IdType="pmc">PMC3981897</ArticleId><ArticleId IdType="pubmed">24681576</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess S, Thompson S. Interpreting findings from mendelian randomization using the Mr-egger method. Eur J Epidemiol (2017) 32(5):377&#x2013;89. doi:&#xa0;10.1007/s10654-017-0255-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-017-0255-x</ArticleId><ArticleId IdType="pmc">PMC5506233</ArticleId><ArticleId IdType="pubmed">28527048</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Davey Smith G, Haycock P, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol (2016) 40(4):304&#x2013;14. doi:&#xa0;10.1002/gepi.21965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21965</ArticleId><ArticleId IdType="pmc">PMC4849733</ArticleId><ArticleId IdType="pubmed">27061298</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones ME, Schoemaker MJ, Wright LB, Ashworth A, Swerdlow AJ. Smoking and risk of breast cancer in the generations study cohort. Breast Cancer Res (2017) 19(1):118. doi:&#xa0;10.1186/s13058-017-0908-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13058-017-0908-4</ArticleId><ArticleId IdType="pmc">PMC5698948</ArticleId><ArticleId IdType="pubmed">29162146</ArticleId></ArticleIdList></Reference><Reference><Citation>Speyer CB, Costenbader KH. Cigarette smoking and the pathogenesis of systemic lupus erythematosus. Expert Rev Clin Immunol (2018) 14(6):481&#x2013;7. doi:&#xa0;10.1080/1744666X.2018.1473035</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2018.1473035</ArticleId><ArticleId IdType="pmc">PMC7069669</ArticleId><ArticleId IdType="pubmed">29724134</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbanck M, Chen C, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet (2018) 50(5):693&#x2013;8. doi:&#xa0;10.1038/s41588-018-0099-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0099-7</ArticleId><ArticleId IdType="pmc">PMC6083837</ArticleId><ArticleId IdType="pubmed">29686387</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson JA. Framework for the investigation of pleiotropy in two-sample summary data mendelian randomization. Stat Med (2017) 36(11):1783&#x2013;802. doi:&#xa0;10.1002/sim.7221</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7221</ArticleId><ArticleId IdType="pmc">PMC5434863</ArticleId><ArticleId IdType="pubmed">28114746</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. . Limma powers differential expression analyses for rna-sequencing and m icroarray studies. Nucleic Acids Res (2015) 43(7):e47. doi:&#xa0;10.1093/nar/gkv007</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. Wgcna: An r package for weighted correlation network analysis. BMC Bioinf (2008) 9:559. doi:&#xa0;10.1186/1471-2105-9-559</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang L-G, Han Y, He Q-Y. Clusterprofiler: An r package for comparing biological themes among Ge Ne clusters. OMICS (2012) 16(5):284&#x2013;7. doi:&#xa0;10.1089/omi.2011.0118</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann S, Castelo R, Guinney J. Gsva: Gene set variation analysis for microarray and rna-seq data. BMC Bioinf (2013) 14:7. doi:&#xa0;10.1186/1471-2105-14-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-7</ArticleId><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara K, Shahmoradgoli M, Mart&#xed;nez E, Vegesna R, Kim H, Torres-Garcia W, et al. . Inferring tumour purity and stromal and immune cell admixture from exp ression data. Nat Commun (2013) 4:2612. doi:&#xa0;10.1038/ncomms3612</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms3612</ArticleId><ArticleId IdType="pmc">PMC3826632</ArticleId><ArticleId IdType="pubmed">24113773</ArticleId></ArticleIdList></Reference><Reference><Citation>Malireddi R, Kesavardhana S, Kanneganti T. Zbp1 and Tak1: Master regulators of Nlrp3 Inflammasome/Pyroptosis, apoptosis, and necroptosis (Pan-optosis). Front Cell Infect Microbiol (2019) 9:406. doi:&#xa0;10.3389/fcimb.2019.00406</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00406</ArticleId><ArticleId IdType="pmc">PMC6902032</ArticleId><ArticleId IdType="pubmed">31850239</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniam S, Maniam S. Small molecules targeting programmed cell death in breast cancer cells. Int J Mol Sci (2021) 22(18). doi:&#xa0;10.3390/ijms22189722</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22189722</ArticleId><ArticleId IdType="pmc">PMC8465612</ArticleId><ArticleId IdType="pubmed">34575883</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Wang K, Li N, Zhang Q, Chen F, Li M. Prognostic and immune implications of a novel pyroptosis-related five-gene signature in breast cancer. Front Surg (2022) 9:837848. doi:&#xa0;10.3389/fsurg.2022.837848</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2022.837848</ArticleId><ArticleId IdType="pmc">PMC9152226</ArticleId><ArticleId IdType="pubmed">35656090</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Bao A, Liu S, Dai F, Gong Y, Cheng Y. A pyroptosis-related gene signature predicts prognosis and immune microenvironment for breast cancer based on computational biology techniques. Front Genet (2022) 13:801056. doi:&#xa0;10.3389/fgene.2022.801056</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.801056</ArticleId><ArticleId IdType="pmc">PMC9021921</ArticleId><ArticleId IdType="pubmed">35464869</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Lv W, Tan Y, He X, Wu Y, Wu M, et al. . Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients. J Transl Med (2022) 20(1):328. doi:&#xa0;10.1186/s12967-022-03535-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03535-z</ArticleId><ArticleId IdType="pmc">PMC9306193</ArticleId><ArticleId IdType="pubmed">35864548</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke AE, Pooley N, Marjenberg Z, Langham J, Nicholson L, Langham S, et al. . Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis. Semin Arthritis Rheum (2021) 51(6):1230&#x2013;41. doi:&#xa0;10.1016/j.semarthrit.2021.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2021.09.009</ArticleId><ArticleId IdType="pubmed">34710720</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Wang Y, Zhang J, Song N, Xu X, Lu Y. The risks of cancer development in systemic lupus erythematosus (Sle) patients: A systematic review and meta-analysis. Arthritis Res Ther (2018) 20(1):270. doi:&#xa0;10.1186/s13075-018-1760-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1760-3</ArticleId><ArticleId IdType="pmc">PMC6282326</ArticleId><ArticleId IdType="pubmed">30522515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C, Sun Y, Chen W, Liao H, Chen M, Tsai C, et al. . Risk factors for mortality in systemic lupus erythematosus patients: Analysis of adult and pediatric cohorts in Taiwan. J Chin Med Assoc (2022) 85(11):1044&#x2013;50. doi:&#xa0;10.1097/jcma.0000000000000783</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/jcma.0000000000000783</ArticleId><ArticleId IdType="pubmed">36343272</ArticleId></ArticleIdList></Reference><Reference><Citation>Benk V, Al-Herz A, Gladman D, Urowitz M, Fortin P. Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancer. Arthritis Rheum (2005) 53(1):67&#x2013;72. doi:&#xa0;10.1002/art.20912</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20912</ArticleId><ArticleId IdType="pubmed">15696566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lone B, Ahmad F, Karna S, Pokharel Y. Supt5h post-transcriptional silencing modulates Pin1 expression, inhibits tumorigenicity, and induces apoptosis of human breast cancer cells. Cell Physiol Biochem (2020) 54(5):928&#x2013;46. doi:&#xa0;10.33594/000000279</Citation><ArticleIdList><ArticleId IdType="doi">10.33594/000000279</ArticleId><ArticleId IdType="pubmed">32961044</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham D, Park P. Adiponectin triggers breast cancer cell death Via fatty acid metabolic reprogramming. J Exp Clin Cancer Res (2022) 41(1):9. doi:&#xa0;10.1186/s13046-021-02223-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-021-02223-y</ArticleId><ArticleId IdType="pmc">PMC8729140</ArticleId><ArticleId IdType="pubmed">34986886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren K, Zhou D, Wang M, Li E, Hou C, Su Y, et al. . Racgap1 modulates Ect2-dependent mitochondrial quality control to drive breast cancer metastasis. Exp Cell Res (2021) 400(1):112493. doi:&#xa0;10.1016/j.yexcr.2021.112493</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2021.112493</ArticleId><ArticleId IdType="pubmed">33485843</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo F, He Z, Mei L, de Garibay G, Herranz C, Garc&#xed;a N, et al. . Modification of Brca1-associated breast cancer risk by hmmr overexpression. Nat Commun (2022) 13(1):1895. doi:&#xa0;10.1038/s41467-022-29335-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29335-z</ArticleId><ArticleId IdType="pmc">PMC8989921</ArticleId><ArticleId IdType="pubmed">35393420</ArticleId></ArticleIdList></Reference><Reference><Citation>King J, Zhang B, Li Y, Li K, Ni J, Saavedra H, et al. . Ttk promotes mesenchymal signaling Via multiple mechanisms in triple negative breast cancer. Oncogenesis (2018) 7(9):69. doi:&#xa0;10.1038/s41389-018-0077-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41389-018-0077-z</ArticleId><ArticleId IdType="pmc">PMC6133923</ArticleId><ArticleId IdType="pubmed">30206215</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaczek A, Markiewicz A, Seroczynska B, Skokowski J, Jaskiewicz J, Pienkowski T, et al. . Prognostic significance of Top2a gene dosage in her-2-Negative breast cancer. Oncologist (2012) 17(10):1246&#x2013;55. doi:&#xa0;10.1634/theoncologist.2012-0023</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2012-0023</ArticleId><ArticleId IdType="pmc">PMC3481890</ArticleId><ArticleId IdType="pubmed">22871798</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X, Zhu L, Lu X, Wang Y, Li R, Jiang G. Kif15 contributes to cell proliferation and migration in breast cancer. Hum Cell (2020) 33(4):1218&#x2013;28. doi:&#xa0;10.1007/s13577-020-00392-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-020-00392-0</ArticleId><ArticleId IdType="pubmed">32578050</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes J, Rugo H, Cescon D, Im S, Yusof M, Gallardo C, et al. . Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. New Engl J Med (2022) 387(3):217&#x2013;26. doi:&#xa0;10.1056/NEJMoa2202809</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2202809</ArticleId><ArticleId IdType="pubmed">35857659</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarrilli G, Businello G, Dieci M, Paccagnella S, Carraro V, Cappellesso R, et al. . The tumor microenvironment of primitive and metastatic breast cancer: Implications for novel therapeutic strategies. Int J Mol Sci (2020) 21(21). doi:&#xa0;10.3390/ijms21218102</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218102</ArticleId><ArticleId IdType="pmc">PMC7662409</ArticleId><ArticleId IdType="pubmed">33143050</ArticleId></ArticleIdList></Reference><Reference><Citation>Malireddi R, Karki R, Sundaram B, Kancharana B, Lee S, Samir P, et al. . Inflammatory cell death, panoptosis, mediated by cytokines in diverse cancer lineages inhibits tumor growth. Immunohorizons (2021) 5(7):568&#x2013;80. doi:&#xa0;10.4049/immunohorizons.2100059</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2100059</ArticleId><ArticleId IdType="pmc">PMC8522052</ArticleId><ArticleId IdType="pubmed">34290111</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladouceur A, Tessier-Cloutier B, Clarke AE, Ramsey-Goldman R, Gordon C, Hansen JE, et al. . Cancer and systemic lupus erythematosus. Rheum Dis Clin North Am (2020) 46(3):533&#x2013;50. doi:&#xa0;10.1016/j.rdc.2020.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2020.05.005</ArticleId><ArticleId IdType="pubmed">32631602</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>